DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities

Y Abuetabh, HH Wu, C Chai, H Al Yousef… - … & molecular medicine, 2022 - nature.com
Antitumor therapeutic strategies that fundamentally rely on the induction of DNA damage to
eradicate and inhibit the growth of cancer cells are integral approaches to cancer therapy …

DNA damage checkpoint kinases in cancer

HL Smith, H Southgate, DA Tweddle… - Expert reviews in …, 2020 - cambridge.org
DNA damage response (DDR) pathway prevents high level endogenous and environmental
DNA damage being replicated and passed on to the next generation of cells via an …

[HTML][HTML] CD44+/CD24‑phenotype predicts a poor prognosis in triple‑negative breast cancer

H Wang, L Wang, Y Song, S Wang… - Oncology …, 2017 - spandidos-publications.com
Cancer stem cells are enriched in triple‑negative breast cancer (TNBC) tumor tissues, which
present strong capacities of proliferation and tumorigenicity. The present study detected the …

Clinical impact of tumor DNA repair expression and T-cell infiltration in breast cancers

AR Green, MA Aleskandarany, R Ali, EG Hodgson… - Cancer immunology …, 2017 - AACR
Impaired DNA repair drives mutagenicity, which increases neoantigen load and
immunogenicity. We investigated the expression of proteins involved in the DNA damage …

WSB1 overcomes oncogene-induced senescence by targeting ATM for degradation

JJ Kim, SB Lee, SY Yi, SA Han, SH Kim, JM Lee… - Cell Research, 2017 - nature.com
Oncogene-induced senescence (OIS) or apoptosis through the DNA-damage response is
an important barrier of tumorigenesis. Overcoming this barrier leads to abnormal cell …

[HTML][HTML] ATM protein is deficient in over 40% of lung adenocarcinomas

LC Villaruz, H Jones, S Dacic, S Abberbock… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Lung cancer is the leading cause of cancer-related mortality in the USA and worldwide, and
of the estimated 1.2 million new cases of lung cancer diagnosed every year, over 30% are …

[HTML][HTML] ATM in breast and brain tumors: a comprehensive review

MA Estiar, P Mehdipour - Cancer biology & medicine, 2018 - ncbi.nlm.nih.gov
The ATM gene is mutated in the syndrome, ataxia-telangiectasia (AT), which is
characterized by predisposition to cancer. Patients with AT have an elevated risk of breast …

Clinicopathological Features and Outcomes in Individuals with Breast Cancer and ATM, CHEK2, or PALB2 Mutations

C Bergstrom, C Pence, J Berg, N Partain… - Annals of Surgical …, 2021 - Springer
Introduction The moderate-penetrance germline mutations ATM, CHEK2, and PALB2 are
implicated in an increased risk of the development of breast cancer. Whether these …

[HTML][HTML] Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio-resistance in breast cancer

N Alsubhi, F Middleton, TMA Abdel-Fatah… - Molecular Oncology, 2016 - Elsevier
Radiation-induced DNA damage activates the DNA damage response (DDR). DDR up-
regulation may predict radio-resistance and increase the risk of early local recurrence …

Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers

A Arora, TMA Abdel-Fatah, D Agarwal… - …, 2016 - academic.oup.com
RECQL5 is a member of the RecQ family of DNA helicases and has key roles in
homologous recombination, base excision repair, replication and transcription. The …